Haemonetics ROE 2006-2019 | HAE

Current and historical return on equity (ROE) values for Haemonetics (HAE) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Haemonetics ROE for the three months ending March 31, 2019 was 18.88%.
Haemonetics ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-03-31 $0.06B $0.67B 8.19%
2018-12-31 $0.05B $0.64B 6.64%
2018-09-30 $0.02B $0.70B 2.85%
2018-06-30 $0.02B $0.67B 2.89%
2018-03-31 $0.05B $0.75B 5.72%
2017-12-31 $-0.02B $0.82B -2.30%
2017-09-30 $0.00B $0.80B 0.52%
2017-06-30 $0.00B $0.77B 0.53%
2017-03-31 $-0.03B $0.74B -3.49%
2016-12-31 $0.02B $0.77B 2.16%
2016-09-30 $-0.06B $0.75B -7.98%
2016-06-30 $-0.07B $0.72B -8.86%
2016-03-31 $-0.06B $0.72B -7.31%
2015-12-31 $-0.05B $0.72B -6.29%
2015-09-30 $0.03B $0.78B 3.22%
2015-06-30 $0.02B $0.79B 2.44%
2015-03-31 $0.02B $0.83B 1.94%
2014-12-31 $0.03B $0.83B 3.51%
2014-09-30 $0.03B $0.82B 3.52%
2014-06-30 $0.04B $0.82B 4.76%
2014-03-31 $0.04B $0.84B 4.33%
2013-12-31 $0.04B $0.83B 4.80%
2013-09-30 $0.03B $0.80B 4.11%
2013-06-30 $0.02B $0.77B 2.84%
2013-03-31 $0.04B $0.77B 5.20%
2012-12-31 $0.05B $0.78B 5.92%
2012-09-30 $0.05B $0.77B 7.15%
2012-06-30 $0.06B $0.76B 8.35%
2012-03-31 $0.07B $0.73B 9.48%
2011-12-31 $0.07B $0.71B 10.07%
2011-09-30 $0.07B $0.68B 10.57%
2011-06-30 $0.08B $0.71B 11.97%
2011-03-31 $0.08B $0.69B 12.83%
2010-12-31 $0.06B $0.65B 10.50%
2010-09-30 $0.06B $0.59B 10.49%
2010-06-30 $0.06B $0.57B 10.04%
2010-03-31 $0.06B $0.59B 10.05%
2009-12-31 $0.07B $0.57B 12.06%
2009-09-30 $0.07B $0.58B 12.01%
2009-06-30 $0.06B $0.56B 11.90%
2009-03-31 $0.06B $0.54B 11.53%
2008-12-31 $0.06B $0.52B 11.79%
2008-09-30 $0.06B $0.50B 11.64%
2008-06-30 $0.05B $0.49B 11.10%
2008-03-31 $0.05B $0.49B 10.99%
2007-12-31 $0.06B $0.47B 12.35%
2007-09-30 $0.06B $0.45B 13.13%
2007-06-30 $0.05B $0.48B 10.93%
2007-03-31 $0.05B $0.48B 10.58%
2006-12-31 $0.05B $0.45B 10.15%
2006-09-30 $0.06B $0.46B 12.82%
2006-06-30 $0.07B $0.46B 15.68%
2006-03-31 $0.07B $0.44B 17.04%
2005-12-31 $0.06B $0.42B 16.17%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $6.254B $0.968B
Haemonetics Corporation is a Global Leader in Blood Management Solutions. Their comprehensive portfolio of devices, information management, consulting services offers blood management solutions for each facet of the blood supply chain from plasma blood collectors to hospitals. They believe that through proper blood management, their portfolio of products and services helps to prevent a transfusion for the patient who doesn't need one and provides the right blood product, at the right time, in the right dose to the right patient who does.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $151.296B 28.49
Medtronic (MDT) Ireland $135.350B 19.33
Stryker (SYK) United States $77.587B 27.69
Boston Scientific (BSX) United States $58.741B 28.16
Baxter (BAX) United States $42.165B 26.58
EssilorLuxottica Societe Anonyme (ESLOY) France $28.527B 0.00
Coloplast (CLPBY) Denmark $25.661B 40.97
Lonza Group Ag (LZAGY) Switzerland $25.304B 0.00
Zimmer Biomet Holdings (ZBH) United States $25.194B 16.19
Terumo (TRUMY) Japan $22.193B 25.52
Smith & Nephew SNATS (SNN) United Kingdom $19.113B 0.00
ResMed (RMD) United States $17.749B 33.91
Canopy Growth (CGC) Canada $12.652B 0.00
Sunny Optical Technology (SNPTF) China $12.175B 0.00
Bio-Rad Laboratories (BIO) United States $9.194B 48.74
Aurora Cannabis (ACB) Canada $7.514B 74.10
William Demant Holdings (WILYY) Denmark $7.411B 0.00
Insulet (PODD) United States $7.236B 527.17
Hill-Rom Holdings (HRC) United States $7.121B 21.59
Perrigo (PRGO) Ireland $6.850B 11.58
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
ICU Medical (ICUI) United States $5.122B 30.57
GW Pharmaceuticals (GWPH) United Kingdom $4.916B 0.00
Neogen (NEOG) United States $3.373B 54.85
NuVasive (NUVA) United States $2.987B 24.39
Hutchison China MediTech (HCM) China $2.906B 0.00
Agios Pharmaceuticals (AGIO) United States $2.848B 0.00
National Vision Holdings (EYE) United States $2.479B 52.82
Quidel (QDEL) United States $2.261B 23.46
Aphria (APHA) $1.646B 0.00
Cardiovascular Systems (CSII) United States $1.530B 878.80
Phibro Animal Health (PAHC) United States $1.212B 18.16
AtriCure (ATRC) United States $1.196B 0.00
VAREX IMAGING (VREX) United States $1.177B 24.98
NanoString Technologies (NSTG) United States $1.065B 0.00
Lantheus Holdings (LNTH) United States $1.052B 27.95
PetIQ (PETQ) United States $1.008B 24.49
Quanterix (QTRX) United States $0.783B 0.00
Cerus (CERS) United States $0.769B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.758B 21.26
Omeros (OMER) United States $0.758B 0.00
MacroGenics (MGNX) United States $0.740B 0.00
TG Therapeutics (TGTX) United States $0.686B 0.00
LeMaitre Vascular (LMAT) United States $0.591B 28.62
Surmodics (SRDX) United States $0.533B 77.45
OraSure Technologies (OSUR) United States $0.522B 24.06
Meridian Bioscience (VIVO) United States $0.489B 14.96
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.398B 0.00
Vapotherm (VAPO) United States $0.337B 0.00
Utah Medical Products (UTMD) United States $0.325B 22.51
BioLife Solutions (BLFS) United States $0.313B 97.88
Zynex (ZYXI) United States $0.242B 24.90
Cytosorbents (CTSO) United States $0.234B 0.00
Bovie Medical (APYX) United States $0.224B 0.00
Chimerix (CMRX) United States $0.184B 0.00
Owens & Minor (OMI) United States $0.178B 3.77
United Health Products (UEEC) United States $0.175B 0.00
Rockwell Medical (RMTI) United States $0.168B 0.00
Female Health (VERU) United States $0.143B 0.00
Fonar (FONR) United States $0.141B 7.40
Chembio Diagnostics (CEMI) United States $0.100B 0.00
United-Guardian (UG) United States $0.091B 19.97
InfuSystems Holdings (INFU) United States $0.088B 0.00
Surface Oncology (SURF) United States $0.076B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.066B 0.00
Trinity Biotech (TRIB) Ireland $0.057B 19.58
MRI INTERVENTNS (MRIC) United States $0.053B 0.00